Skip to content
★ Sign in to follow
Republic Healthcare Ltd. logo

Republic Healthcare Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$129.8MHealth Care

No insider purchase over the last 90 days. The latest, by Tan Cher Sen Alan, was filed 12 May 2026.

Republic Healthcare Ltd.: what insiders have been doing

Republic Healthcare Ltd. belongs to the Health Care sector. Filings by its managers are published through HKEX. From 22 October 2025 to 22 October 2026, the disclosure feed for Republic Healthcare Ltd. logged 2 filings by 1 insider.

No insider sold shares on the market over the period. Instead, the filings list 2 purchases totalling €5,151, made by 1 insider. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. At €4,065, the purchase published on 11 May 2026 by Tan Cher Sen Alan is the largest of the period (0.056% of market cap). The buyers include 1 senior executive.

Across the 1,314 companies tracked on its exchange, the median is 4 filings; at 2 filings, this issuer sits below that mark. Looking back to 2018, when coverage begins, insiders filed 5 purchases and 1 sale.

The latest purchase dates back some time: it was published 180 days ago, on 12 May 2026.

In the same sector, recent insider purchases at UCB also feature in our signals. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.

Insider Decl.
7
Thresholds
n/a
Buy Volume
€564,903
5 ops. · all time
Sell Volume
€1M
1 ops. · all time

Who traded when

BuySale
Tan Cher Sen Alan3 buys
Wang Liang2 buys

Since the insiders bought

  • Filed 12 May 2026 · 180 days ago · €1,086
    -6.7%
    Entry HK$0.13 · Close at T+90 HK$0.12
  • Filed 11 Sept 2025 · 423 days ago · €81k
    -15.1%
    Entry HK$0.15 · Close at T+365 HK$0.13

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 21,707 of 26,897 companies
30.1
score / 100
Value
27
Quality
33
FCF yld-2.6%
Earn yld-2.3%
EV/EBITDA·
ROE-35%
Gross mgn68%
Net mgn-38%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$0.21
Analyst consensus
·
Income statement
RevenueHK$8M
Gross profitHK$5.4M68% margin
EBITDA-HK$2M-25% margin
Net income-HK$3M-39.4% margin
Valuation
P/Book2.6x
Beta1.20
Balance sheet & cash
Market capHK$129.8M
Total debtHK$5M
Free Cash Flow-HK$3.3M
Debt / Equity43%
Profitability & ownership
ROE-35.2%
ROA-15.7%
% insiders69.8%
% institutions0.0%
Last declaration on 12 May 2026
Declarations7 total
  • ▲
    DirectorExecutives
    9,979 HKD13HKEX
    85,000 shares@ HK$0.11740.015% mcap21.1% of flowShareXHKGHKEX:DA20260512E00010
    Canonical exit: 6 Aug 2026 (T+90)
  • ▲
    DirectorExecutives
    37,364 HKD19HKEX
    285,000 shares@ HK$0.13110.056% mcap78.9% of flowShareXHKGHKEX:DA20260508E00427
    Canonical exit: 5 Aug 2026 (T+90)
  • ▲
    DirectorExecutives
    739,500 HKD12HKEX
    5,100,000 shares@ HK$0.14514.8% of flowShareXHKGHKEX:DA20250911E00028
    Canonical exit: 9 Dec 2025 (T+90)
  • ▲
    DirectorExecutives
    4M HKD19HKEX
    26,100,000 shares@ HK$0.16285.2% of flowShareXHKGHKEX:DA20250825E00008
    Canonical exit: 19 Nov 2025 (T+90)
  • ▲
    DirectorExecutives
    112,200 HKD11HKEX
    1,275,000 shares@ HK$0.0881.1% of flowShareXHKGHKEX:DA20250522E00014
    Canonical exit: 18 Aug 2025 (T+90)
  • ▼
    DirectorExecutives
    10M HKD19HKEX
    40,000,000 shares@ HK$0.24898.4% of flowShareXHKGHKEX:DA20210930E00231
  • ●
    DirectorExecutives
    0HKEX
    390,000,000 sharesShareXHKGHKEX:DA20180620E00131

7 of 7 declarations

About Republic Healthcare Ltd.

Republic Healthcare Ltd. is a company focused on the healthcare and pharmaceutical sector. It is listed on the Hong Kong Stock Exchange, XHKG.